Archer Investment Corporation’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.87M Sell
7,467
-265
-3% -$269K 1.46% 11
2025
Q4
$8.31M Buy
7,732
+150
+2% +$143K 1.87% 7
2025
Q3
$5.79M Buy
7,582
+4,797
+172% +$3.57M 1.31% 12
2025
Q2
$2.17M Sell
2,785
-8
-0.3% -$6.22K 0.52% 42
2025
Q1
$2.31M Sell
2,793
-34
-1% -$28.3K 0.6% 38
2024
Q4
$2.18M Buy
2,827
+99
+4% +$82K 0.58% 40
2024
Q3
$2.42M Sell
2,728
-386
-12% -$347K 0.65% 35
2024
Q2
$2.82M Buy
3,114
+19
+0.6% +$15.2K 0.82% 28
2024
Q1
$2.41M Sell
3,095
-489
-14% -$348K 0.72% 32
2023
Q4
$2.09M Sell
3,584
-298
-8% -$174K 0.67% 32
2023
Q3
$2.08M Buy
3,882
+12
+0.3% +$6.18K 0.73% 27
2023
Q2
$1.82M Buy
3,870
+82
+2% +$34.4K 0.65% 35
2023
Q1
$1.21M Buy
3,788
+249
+7% +$84K 0.45% 52
2022
Q4
$1.29M Buy
3,539
+46
+1% +$16.3K 0.5% 46
2022
Q3
$1.13M Buy
3,493
+1
+0% +$317 0.48% 48
2022
Q2
$1.13M Buy
3,492
+650
+23% +$195K 0.46% 55
2022
Q1
$819K Buy
2,842
+831
+41% +$214K 0.29% 84
2021
Q4
$556K Sell
2,011
-10
-0.5% -$2.54K 0.19% 133
2021
Q3
$467K Hold
2,021
0.17% 141
2021
Q2
$464K Buy
2,021
+1,801
+819% +$362K 0.18% 133
2021
Q1
$41.2K Hold
220
0.02% 368
2020
Q4
$37.1K Buy
220
+100
+83% +$14.9K 0.02% 354
2020
Q3
$17.8K Hold
120
0.01% 380
2020
Q2
$19.7K Hold
120
0.01% 350
2020
Q1
$17K Hold
120
0.01% 371
2019
Q4
$16K Buy
120
+10
+9% +$1.16K 0.01% 406
2019
Q3
$12K Hold
110
0.01% 325
2019
Q2
$12K Hold
110
0.01% 326
2019
Q1
$14K Sell
110
-272
-71% -$33.1K 0.01% 312
2018
Q4
$44K Buy
+382
New +$42.7K 0.04% 231

Other funds holding LLY

Archer Investment Corporation's LLY Position: Q1 2026 in Review

Archer Investment Corporation reduced its Eli Lilly (LLY) stake by 3.4% in Q1 2026, selling an estimated $269K and leaving 7,467 shares worth $6.87M. The position accounts for 1.46% of the portfolio, ranked #11.

Archer Investment Corporation first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $8.31M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Archer Investment Corporation held 7,467 shares of Eli Lilly worth $6.87M as of Q1 2026.
  • Archer Investment Corporation sold 265 Eli Lilly shares in Q1 2026, an estimated $269K.
  • Eli Lilly made up 1.46% of Archer Investment Corporation's portfolio in Q1 2026, its #11 holding.
  • Archer Investment Corporation first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Archer Investment Corporation's Eli Lilly position peaked at $8.31M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Archer Investment Corporation's 13F filing for Q1 2026, filed 4 May 2026.